Five Prime Therapeutics Inc (NASDAQ:FPRX)

16.14
Delayed Data
As of Apr 20
 +0.10 / +0.62%
Today’s Change
15.66
Today|||52-Week Range
48.87
-26.37%
Year-to-Date
No recent news for Five Prime Therapeutics Inc.

Today’s Trading

Previous close16.04
Today’s open16.00
Day’s range15.77 - 16.18
Volume266,307
Average volume (3 months)559,075
Market cap$672.8M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-120.49%
Earnings growth (this year)+23.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+28.73%
P/E ratioNM
Price/Sales15.50
Price/Book2.05

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.01+0.04%
EDITEditas Medicine Inc-0.35-1.01%
MYOVMyovant Sciences Ltd+0.37+1.78%
EPZMEpizyme Inc-0.20-1.25%
Data as of 4:01pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$1.12
Annual revenue (last year)$39.5M
Annual profit (last year)-$150.2M
Net profit margin-380.23%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Aron M. Knickerbocker
Chief Financial &
Accounting Officer
Linda M. Rubinstein
Corporate headquarters
South San Francisco, California

Forecasts